Canlyniadau Chwilio - Torsten Zimmermann
- Dangos 1 - 2 canlyniadau o 2
-
1
The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial gan Antonia M. Joussen, Sebastián Wolf, Peter K. Kaiser, David S. Boyer, Thomas Schmelter, Rupert Sandbrink, Oliver Zeitz, Gesa Deeg, Annett Richter, Torsten Zimmermann, Joachim Hoechel, Ulf Buetehorn, Walter Schmitt, Brigitte Stemper, Michael Karl Boettger
Cyhoeddwyd 2018Artigo -
2
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106 gan Akihiro Takano, Fredrik Piehl, Jan Hillert, Andrea Varrone, Sangram Nag, Balázs Gulyás, Per Stenkrona, Victor L. Villemagne, Christopher C. Rowe, Richard Macdonell, Nabil Al Tawil, Thomas Kucinski, Torsten Zimmermann, Marcus Schultze‐Mosgau, Andrea Thiele, Anja Hoffmann, Christer Halldin
Cyhoeddwyd 2013Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Internal medicine
Medicine
Adverse effect
Aflibercept
Bevacizumab
Binding potential
Biology
Biotechnology
Cancer
Chemotherapy
Choroidal neovascularization
Clinical trial
Colorectal cancer
Immunology
In vivo
Inflammation
Macular degeneration
Magnetic resonance imaging
Microglia
Multiple sclerosis
Neuroinflammation
Nuclear medicine
Open label
Ophthalmology
Pathology
Pet imaging
Phases of clinical research
Positron emission tomography
Radioligand
Radiology